Navigation Links
The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
Date:9/22/2007

National Cervical Cancer Coalition unites women in joining the fight for education and early detection and prevention of the Human Papillomavirus

(HPV) and cervical cancer

WASHINGTON, Sept. 21 /PRNewswire-USNewswire/ -- More than 80 women and men gathered at the Hyatt Regency Capitol Hill in the heart of Washington, D.C. to attend the First Annual Cervical Cancer/HPV Conference, conducted by the National Cervical Cancer Coalition (NCCC). During the two-day conference, controversial issues such as nationally mandating the cervical cancer vaccine for young women were tackled, as well as the discussion of debunking the stigma associated with HPV, a Sexually Transmitted Infection (STI). The conference marks the first time women with HPV and cervical cancer gathered together in the United States to discuss the disease, treatments and prevention.

Perhaps one of the most important prevention topics discussed during the conference was presented by Juan C. Felix, M.D., professor of pathology and obstetrics and gynecology, Keck School of Medicine of the University of Southern California, in regards to the new HPV vaccines. When attendees were asked during the beginning of the conference whether or not they would support a national mandate for all girls entering middle school to get the HPV vaccine, a little more than 42 percent could agree. After listening to Dr. Felix, and receiving all the facts and information, the NCCC took a second vote using a real-time computerized voting system and discovered more than 70 percent now advocated mandating the vaccine for girls between the ages of 9 and 13, as long as there was an "opt-out" offered to parents with objections. Of course, the attendees stressed that getting screened and having their routine PAP test, when coupled with an HPV test, is still the most effective early detection method available to women.

Additional HPV facts presented during the conference came from Heidi Bauer, M.D. MPH, California Department of Public Health and of the California STD/HIV Prevention Training center included:

-- Currently, there are more than 20 million people infected with a

genital HPV infection in the U.S.

-- There are 6.2 million new HPV infections annually, with more than 80

percent of people (men and women) acquiring the infection at some point

in their lives

-- Sixty percent of girls will contract the HPV infection by the time they

are 16 years of age or within 4 years of sexual debut.

-- Of the girls infected, 2/3 will clear the infection within 2 years

without intervention, although 10 percent will not be able to clear

infection at all and will go on to develop high-risk HPV or cervical

cancer

-- HPV is considered the "common cold" of STIs

-- Strains 16 and 18 account for more than 70 percent of HPV infections

-- Type 16 is responsible for more than half of all cervical cancers,

which Cervarix (GlaxoSmithKline) and Gardasil (Merck) are designed to

specifically target

Attending the conference were women, their families and friends from across the United States, all of whom have been affected in some way by HPV and/or cervical cancer, whether survivors or those seeking additional information. The main goal for the conference was to educate these women and provide them with the tools and information they need to become advocates for HPV and cervical cancer prevention within their own communities.

Inspiring a sisterhood among attendees, the women also focused on the stigma attached to having this specific type of cancer, especially since it is related to a sexually transmitted infection. Many women were made to feel shamed or dirty when they were diagnosed with HPV, even though it is the most common sexually transmitted infection. Many women addressed the fact that when they received their diagnosis of cervical cancer, they had never even heard of HPV or were aware it caused cancer.

"Having cervical cancer does make others assume the worst about you. The fact that the average person who is HPV positive has only had 2.1 sexual partners shows this is can happen to anyone," said Shawna Dickey, a 33-year- old survivor of adenocarcinoma from Packwood, Iowa, who attended the conference. "The lack of awareness as to how many people have contracted HPV at some time in their life shows how little the public is informed. So many people have it and don't even realize they are carriers."

In the United States, cervical cancer is the second leading cause of cancer related death in women between 20 and 39 years old. More than 14,000 women in the U.S. are diagnosed with cervical cancer each year and more than 3,900 women will die from this devastating disease. In developing nations, cervical cancer remains the number-one cause of cancer related deaths, with an estimated 493,000 cervical cancer cases being diagnosed each year, accounting for more than 85 percent of new diagnosis. Of those 493,000 cases, an estimated 273,500 women will die from this preventable disease.

About National Cervical Cancer Coalition

Proud to be celebrating its 10 year anniversary, the National Cervical Cancer Coalition (NCCC) is the nation's oldest non-profit organization exclusively focused on working with women and family members and friends that are battling issues related to cervical cancer and HPV. To directly support these initiatives, the NCCC launched an online cervical cancer/HPV site at http://cervicalcancer.clinicahealth.com, as well as created cervical cancer quilts that travel the nation to help place a personal face on the battle against cervical cancer.

In addition, the NCCC has a comprehensive, award-winning informational Web site, where visitors can find the latest information. For more information, the NCCC can be found on the Web at http://www.nccc-online.org or please call 800-685-5531.


'/>"/>
SOURCE National Cervical Cancer Coalition
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... N.J. , Feb. 12, 2016  Innophos Holdings, Inc. ... and nutritional specialty ingredients, today announced that it will host ... 10:00 am ET to discuss its fourth quarter and full ... --> The press release detailing fourth quarter and full ... after market close. --> ...
(Date:2/12/2016)... 2016 (Kanadische ... http://www.sedar.com ) und der Website ... --> http://www.sedar.com ) und ... abrufbar.    --> Telesta ... Konzernabschluss des zweiten Quartals und die ...
(Date:2/12/2016)... JOSE, Calif. , Feb. 12, 2016  SI-BONE, Inc., a ... System ® ("iFuse"), a minimally invasive surgical (MIS) device indicated ... that National Government Services, Inc. (NGS), the Medicare Administrative Contractor (MAC) ... Illinois , Maine , Massachusetts ... , New York , Rhode ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... The law firm of Morrow, Morrow, ... The purpose of these scholarships is to encourage applicants to pursue a degree ... employment within these two parishes. , “We have available jobs in St. Landry ...
(Date:2/12/2016)... VA (PRWEB) , ... February 12, 2016 , ... CDRH Enforcement Trends: , Back to ... , As Winston Churchill said, “Those who don’t learn from history ... show what to expect when they come knocking this year. But that takes time. ...
(Date:2/12/2016)... Angeles, CA (PRWEB) , ... February 12, 2016 , ... ... With a hectic schedule, a demanding job, and no time to decompress, Rabinowitz found ... she dedicated herself to meditation for its impact on her life, implementing a 20-minute-per-day ...
(Date:2/12/2016)... Appleton, Wis. (PRWEB) , ... February 12, 2016 ... ... its second Lean Leadership Series at Zuckerberg San Francisco General Hospital on April ... to practice new behaviors and create new habits. The workshops cover a broad ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fisher House Foundation Chairman ... John J. Lee, Nevada Military Support Alliance president Scott Bensing, and Peggy Kearns Director, ... VA Southern Nevada Healthcare System. This will be the first Fisher House in ...
Breaking Medicine News(10 mins):